PURPOSE: Routine deep venous thrombosis prophylaxis is controversial in Asian patients, because deep venous thrombosis incidence was considered negligible. Because of recent reports of significantly higher incidences, a randomized, controlled trial was conducted to assess the effectiveness and complications of enoxaparin prophylaxis (low molecular weight heparins) in major colorectal surgery. METHODS:Three hundred twenty consecutive patients were randomly assigned to control or low molecular weight heparins groups. Patients in the low molecular weight heparins group were given perioperative enoxaparin starting 12 hours before surgery. The surgeon (blinded) assessed for difficulties related to possible enoxaparin administration. Independent blinded observers performed daily clinical assessments and Doppler studies (at the 3rd and 5th postoperative day). Deep venous thrombosis was confirmed by duplex ultrasound, and pulmonary embolism was confirmed by lung scans or postmortem examinations. RESULTS:Deep venous thrombosis developed in 5 of 169 (3 percent) controls and 0 of 134 low molecular weight heparins patients (P = 0.045). Three of the deep venous thrombosis patients had pulmonary embolism, which was fatal in one patient. The surgeons were unable to perceive any increased surgical difficulties in the low molecular weight heparins group. The bleeding-related complications were significantly higher in the low molecular weight heparins patients (controls, n = 3 (1.8 percent); low molecular weight heparins, n = 9 (6.7 percent)). However, apart from one subdural hematoma and two abdominal hemorrhages needing re-exploration, which also occurred in one of the controls, these complications were minor bruises at the wounds, drains, or injection sites. CONCLUSION:Deep venous thrombosis prophylaxis is needed in Asian patients undergoing major colorectal surgery.
RCT Entities:
PURPOSE: Routine deep venous thrombosis prophylaxis is controversial in Asian patients, because deep venous thrombosis incidence was considered negligible. Because of recent reports of significantly higher incidences, a randomized, controlled trial was conducted to assess the effectiveness and complications of enoxaparin prophylaxis (low molecular weight heparins) in major colorectal surgery. METHODS: Three hundred twenty consecutive patients were randomly assigned to control or low molecular weight heparins groups. Patients in the low molecular weight heparins group were given perioperative enoxaparin starting 12 hours before surgery. The surgeon (blinded) assessed for difficulties related to possible enoxaparin administration. Independent blinded observers performed daily clinical assessments and Doppler studies (at the 3rd and 5th postoperative day). Deep venous thrombosis was confirmed by duplex ultrasound, and pulmonary embolism was confirmed by lung scans or postmortem examinations. RESULTS:Deep venous thrombosis developed in 5 of 169 (3 percent) controls and 0 of 134 low molecular weight heparinspatients (P = 0.045). Three of the deep venous thrombosispatients had pulmonary embolism, which was fatal in one patient. The surgeons were unable to perceive any increased surgical difficulties in the low molecular weight heparins group. The bleeding-related complications were significantly higher in the low molecular weight heparinspatients (controls, n = 3 (1.8 percent); low molecular weight heparins, n = 9 (6.7 percent)). However, apart from one subdural hematoma and two abdominal hemorrhages needing re-exploration, which also occurred in one of the controls, these complications were minor bruises at the wounds, drains, or injection sites. CONCLUSION:Deep venous thrombosis prophylaxis is needed in Asian patients undergoing major colorectal surgery.
Authors: Anandan Murugesan; Dina N Srivastava; Uma K Ballehaninna; Sunil Chumber; Anita Dhar; Mahesh C Misra; Rajinder Parshad; V Seenu; Anurag Srivastava; Narmada P Gupta Journal: Indian J Surg Date: 2010-11-16 Impact factor: 0.656
Authors: Daniel W Nelson; Vlad V Simianu; Amir L Bastawrous; Richard P Billingham; Alessandro Fichera; Michael G Florence; Eric K Johnson; Morris G Johnson; Richard C Thirlby; David R Flum; Scott R Steele Journal: JAMA Surg Date: 2015-08 Impact factor: 14.766
Authors: Gianluca Costa; Laura Lorenzon; Giulia Massa; Barbara Frezza; Mario Ferri; Pietro Fransvea; Paolo Mercantini; Maria Cristina Giustiniani; Genoveffa Balducci Journal: Int J Colorectal Dis Date: 2017-07-28 Impact factor: 2.571
Authors: Aslam Ejaz; Gaya Spolverato; Yuhree Kim; Donald L Lucas; Brandyn Lau; Matthew Weiss; Fabian M Johnston; Marin Kheng; Marian Kheng; Kenzo Hirose; Christopher L Wolfgang; Elliott Haut; Timothy M Pawlik Journal: J Gastrointest Surg Date: 2013-12-13 Impact factor: 3.452
Authors: Danson X W Yeo; Sameer Junnarkar; Sunder Balasubramaniam; Yen Pin Tan; Jee Keem Low; Winston Woon; Tony Chun Yeung Pang Journal: World J Surg Date: 2015-01 Impact factor: 3.352
Authors: Song-Soo Yang; Chang Sik Yu; Yong Sik Yoon; Sang Nam Yoon; Seok-Byung Lim; Jin Cheon Kim Journal: World J Surg Date: 2011-04 Impact factor: 3.352
Authors: Tanveer Iqbal Dar; Khursheed Alam Wani; Mohd Ashraf; Aijaz Malik; Sanjeed Ahmad; Tariq A Gojwari; Arshad Iqbal Journal: Indian J Crit Care Med Date: 2012-04